Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
STANDARD BIOTOOLS INC.
| Metric | STANDARD BIOTOOLS INC. LABHealthcare |
|---|---|
| Quality Score | 35 / 100 |
| Revenue (latest) | $85M |
| Net income (latest) | −$75M |
| Operating margin | −129.2% |
| Net margin | −87.8% |
| Return on equity | −17.7% |
| Return on assets | −13.2% |
| Return on capital (ROCE) | −24.0% |
| Debt / equity | 0.34× |
| Revenue growth (YoY) | −6.2% |
| Altman Z″ (distress) | -1.44 |
| Accruals / assets | −0.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.